York / Oxford / Washington / Nottingham / Hoboken / Baltimore / New York / Cambridge / London / /
Company
Novartis / GAG Biosciences / Agency for the Evaluation / G.L. A.S. / Amgen / Axis-Shield / Roche Diagnostics / Celera Diagnostics / Orchid Biosciences / Ono Pharmaceuticals / GlaxoSmithKline / Merck / Regulating Pharmaceuticals / Warner Lambert / Holtzman N. A. / Pharmacia / Wyeth / Abbott Laboratories / Novo Nordisk / Sanofi Syntholabo / Bristol-Myers Squibb / Includes Parke-Davis / Bayer / Aventis / The Wellcome Trust / PGx / Lilly / Affymetrix / Sankyo / Pfizer / Company Founded Location Focus Acadia Pharmaceuticals / Becton Dickinson / A.W. / Green S. A. / Schering / First Genetic Trust / AstraZeneca / Campen L. C. / Myriad Genetics / /
Continent
Europe / /
Country
United Kingdom / United States / /
Currency
pence / /
Event
Funding / FDA Phase / Business Partnership / Product Issues / Product Recall / /
Facility
University of York / University of Nottingham / University of York Science / University of Oxford / Bartholomew’s Hospital / /
IndustryTerm
pharmaceutical industry / biotechnology industries / cancer therapy / large pharmaceutical / pharmacogenetic applications / genetic analysis services / high healthcare costs / medicinal products / genetics services / manufacturing information / specialist services / treatment of breast cancer / healthcare providers / biotechnology / public health systems / patient testing services / health-care systems / pharmaceutical / diagnostic products / treatment of HIV / reduced healthcare costs / banking / treatment of irritable bowel syndrome / /
MedicalCondition
HIV / complex disease / arthritis / illness / breast cancer / cancer / genetic disease / schizophrenia / chronic heart failure / J. Cancer / specific disease / AGRANULOCYTOSIS A / atrial fibrillation / irritable bowel syndrome / inflammatory bowel disease / fatal blood disorders / blood clots / leukaemia / infections / PORPHYRIA / AGRANULOCYTOSIS / H. Cancer / disease / heart failure / venous thromboembolism / tuberculosis / /
MedicalTreatment
cancer therapy / gene therapy / drug therapy / /
Organization
Centre for Drug Evaluation / Nuffield Council of Bioethics / office of Public Affairs / Department of Medicines Management / Science and Technology Studies Unit / University of Oxford / Audit Commission / Taiwan PGx association / European Commission / European Union / Department of Health / NHS / Institute for the Study of Genetics / US PGx association / University of York / S. B. A / UK government / Stationary Office / PGx association / European Agency for the Evaluation of Medicinal Products / Johns Hopkins Univ. / US Clinical PGx association / France (Switzerland) Association / University of York Science and Technology Studies Unit / St. Bartholomew’s Hospital in London / US Food and Drug Administration / University of Nottingham / UK PGx association / Department of Public Health and Primary Care / Keele Univ / Institute for Study of Genetics / European Medicines Evaluation Agency / /
Person
Andrew Webster / Mark McClellan / Vita Genomics / Paul Martin / Graham Lewis / Archibald Garrod / Issa / Andrew Smart / /
Position
physician / candidate for setting policy priorities / Pharmacogenomics Reporter / statement The author / model / perceptive physician-scientist / Commissioner / /
FOCUS ON PHARMACOGENETICS 29. Jones, B. C. et al. Quantitative-trait loci analysis of cocaine-related behaviours and neurochemistry. Pharmacogenetics 9, 607–[removed]Port, J. D. & Bristow, M. R. Altered β-adren